Chiyoda, Japan Related Funds
| Fund Name | Location |
| Audix | New Taipei, Taiwan |
| Bekaert | Belgium, West-Vlaanderen, Zwevegem |
| Edgewood Partners Insurance Center | California, San Francisco, United States |
| EllisDon | Canada, London, Ontario |
| GameWith | Chiba, Japan, Minato |
| Garden State Life Sciences Venture | Pennsylvania, Philadelphia, United States |
| HackerOne | California, San Francisco, United States |
| Jambhala | - |
| JFE Accelerator | New York, New York, United States |
| National Institute for Health Research | Orkney, United Kingdom, Whitehall |
| Nikko Antfactory | - |
| PineBridge Investments | New York, New York, United States |
| Sinclair Broadcast Group | Hunt Valley, Maryland, United States |
| SPDB International Holdings | China, Hong Kong, Hong Kong Island |
| SQFive Intelligent Oilfield Solutions | Alberta, Calgary, Canada |
| SWS Ventures | Canada, Ontario, Toronto |
| University of Illinois | Champaign, Illinois, United States |
| Yao Capital | China, Shanghai |
| Yiguo Group | Changning, China, Shanghai |
| Zheshang Securities | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Luxna Biotech | $5M | 10 Feb 2020 | Osaka, Osaka Prefecture, Japan | ||
Peptidream | $682K | 22 Jul 2008 | Japan, Chiyoda |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Luxna Biotech | $5M | 10 Feb 2020 | Osaka, Osaka Prefecture, Japan | ||
Peptidream | $682K | 22 Jul 2008 | Japan, Chiyoda |
